| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/27/2000 | WO2000043372A1 Acyl derivatives which treat vla-4 related disorders |
| 07/27/2000 | WO2000043369A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043366A1 Quinoline derivatives and quinazoline derivatives |
| 07/27/2000 | WO2000043362A1 Phenylsulphonyl derivatives as 5-ht receptor ligands |
| 07/27/2000 | WO2000043032A2 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 07/27/2000 | WO2000023433A8 Substituted benzopyran analogs for the treatment of inflammation |
| 07/27/2000 | WO2000020399A3 Use of substituted 5-hydroxypyrazoles, novel 5-hydroxypyrazoles, methods for the production thereof and agents containing the same |
| 07/27/2000 | WO2000018767A3 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands |
| 07/27/2000 | WO2000018358A3 Method of treating hair loss using ketoamides |
| 07/27/2000 | WO2000012500A3 2-aryl-4-(1-[4-heteroaryl]piperazin-1-yl) methylimidazoles: dopamine d4 receptor subtype ligands |
| 07/27/2000 | WO2000008202A9 3-methylidenyl-2-indolinone modulators of protein kinase |
| 07/27/2000 | WO2000003743A9 Use of inhibitors of prenyltransferases for inhibiting fungal growth |
| 07/27/2000 | WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors |
| 07/27/2000 | WO1999064033A9 Phosphodiesterase-v modulator drugs and their uses |
| 07/27/2000 | WO1999063994A9 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE |
| 07/27/2000 | WO1999062881A8 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 07/27/2000 | CA2360062A1 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 07/27/2000 | CA2359983A1 Phenylsulphonyl derivatives as 5-ht receptor ligands |
| 07/27/2000 | CA2359680A1 Kinase inhibitors |
| 07/27/2000 | CA2359114A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/26/2000 | EP1022270A1 Pyrazole derivatives |
| 07/26/2000 | EP1022029A1 Nootropic agent |
| 07/26/2000 | EP1021437A1 Arylsulfonylimidazolone derivatives as an antitumor agent |
| 07/26/2000 | EP1021436A1 ETHYL 4-(8-CHLORO-5, 6-DIHYDRO-11H- BENZO 5,6]CYCLOHEPTA 1,2-b]PYRIDIN -11-YLIDENE)-1- PIPERIDENE CARBOXYLATE POLYMORPH |
| 07/26/2000 | EP1021432A1 Halogen substituted tetracyclic tetrahydrofuran derivatives |
| 07/26/2000 | EP1021417A1 Substituted phenyluracils |
| 07/26/2000 | EP1021415A1 Tricyclic aminoalkylcarboxamides; novel dopamine d 3? receptor subtype specific ligands |
| 07/26/2000 | EP1021413A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 07/26/2000 | EP1021411A1 Benzamide derivatives as thrombin inhibitors |
| 07/26/2000 | EP1021410A1 Prostaglandin agonists and their use to treat bone disorders |
| 07/26/2000 | EP1021405A1 Azetidinone derivatives for the treatment of hcmv infections |
| 07/26/2000 | EP1021404A1 Azetidinone derivatives for the treatment of hcmv infections |
| 07/26/2000 | EP1021188A1 Inhibitors of prenyl-protein transferase |
| 07/26/2000 | EP1021185A1 Didhydropyrimidines and uses thereof |
| 07/26/2000 | EP1021182A1 Indeno[1,2-c] pyrazole derivatives for inhibiting tyrosine kinase activity |
| 07/26/2000 | EP1021173A1 Use of csaid?tm compounds for the management of uterine contractions |
| 07/26/2000 | EP0556393B1 Fused pyrazine derivative |
| 07/26/2000 | CN1261363A Method of manufacturing sertindole |
| 07/26/2000 | CN1261362A Omeprazole sodium salt |
| 07/26/2000 | CN1261361A 5-(2-Ethyl-2H-tetrazol-5-Y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate |
| 07/26/2000 | CN1261350A Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors |
| 07/26/2000 | CN1261348A Dihydropyridine derivatives |
| 07/26/2000 | CN1261277A Novel substituted imidazole compounds |
| 07/26/2000 | CN1261276A Protease inhibitors |
| 07/26/2000 | CN1054844C N-substituted azabicycloheptane derivatives, their preparation and use |
| 07/26/2000 | CN1054743C Argatroban consentrated aqueous solution |
| 07/25/2000 | US6093827 Process for the preparation of 10,11-dihydro-5H-dibenzo[A,D]cyclohept-5-enes and derivatives thereof |
| 07/25/2000 | US6093822 5-arylindole derivatives |
| 07/25/2000 | US6093821 Process for preparing steroid receptor modulator compounds |
| 07/25/2000 | US6093812 Process for the stereospecific synthesis of azetidinones |
| 07/25/2000 | US6093737 2-oxo-piperidine substituted imidazole derivatives |
| 07/25/2000 | US6093735 Selective β-3 adrenergic agonists |
| 07/25/2000 | US6093734 Pyridyl methyl sulfinyl benzimidazole type proton pump inhibitor drugs having a hydrolyzable sulfinyl or arylsulfonyl group attached to the benzimidazole nitrogen; gastrointestinal disorders |
| 07/25/2000 | US6093732 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| 07/25/2000 | US6093731 Isoquinolines |
| 07/25/2000 | US6093727 A selective agonists for human alpha 2 receptors for treating disorders as hypertension, pain, glaucoma, alcohol and drug withdrawal, ischemia, rheumatoid arthritis, migraine, cognitive deficiency, spasticity, diarrhea, nasal congestion |
| 07/25/2000 | US6093718 An oxido-squalene cyclase inhibitor, anticholesterol agent for inhibiting cholesterol biosynthesis and lowering cholesterol levels in blood plasma; treating hypercholesterolemia and atherosclerosis |
| 07/25/2000 | US6093716 Substituted 2-pyrimidineamines and processes for their preparation |
| 07/25/2000 | CA2272597A1 Quaternary ammonium salts of sulfonylurea |
| 07/25/2000 | CA2197086C (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
| 07/20/2000 | WO2000042038A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | WO2000042037A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | WO2000042036A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | WO2000042035A1 4-(heterocyclylsulfonamido) -5-methoxy-6- (2-methoxyphenoxy) -2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 07/20/2000 | WO2000042034A1 Phenanthridine-n-oxides with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042026A1 Non-peptide glp-1 agonists |
| 07/20/2000 | WO2000042020A1 Phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042019A1 6-arylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042011A1 Amide compounds |
| 07/20/2000 | WO2000042009A1 Stable activated novel carbamic acid derivatives, preparation method and use for preparing urea |
| 07/20/2000 | WO2000041698A1 φ-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS |
| 07/20/2000 | WO2000041697A1 Utilisation of 2-substituted 1,2-benzisothiazole derivatives and 3-substituted tetrahydropyridopyrimidinone derivatives for the prophylaxis and therapy of cerebral ischaemia |
| 07/20/2000 | WO1999064048A9 Inhibitors of hiv reverse transcriptase |
| 07/20/2000 | WO1999000373A8 Benzimidazole derivatives |
| 07/20/2000 | CA2359952A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | CA2359942A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | CA2359449A1 Phenanthridine-n-oxides with pde-iv inhibiting activity |
| 07/20/2000 | CA2359416A1 6-arylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | CA2359390A1 Utilisation of 2-substituted 1,2-benzisothiazole derivatives and 3-substituted tetrahydropyridopyrimidinone derivatives for the prophylaxis and therapy of cerebral ischaemia |
| 07/20/2000 | CA2359244A1 .omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors |
| 07/19/2000 | EP1020462A1 Heterocyclic compounds and antitumor agent containing the same as active ingredient |
| 07/19/2000 | EP1020461A2 Use of alkaline salts of the (-)-enantiomer of omeprazole |
| 07/19/2000 | EP1020460A2 The sodium salt of the (-)-enantiomer of omeprazole |
| 07/19/2000 | EP1020459A1 Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives |
| 07/19/2000 | EP1020453A1 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid deri vatives, addition salts thereof, and processes for the preparation of both |
| 07/19/2000 | EP1020452A1 Benzimidazole derivatives |
| 07/19/2000 | EP1020448A2 Arylheterocycles with herbicidal activity |
| 07/19/2000 | EP1020446A1 Naphthalimidobenzamide derivatives |
| 07/19/2000 | EP1020445A1 Fused pyridine derivatives |
| 07/19/2000 | EP1020434A1 3-amidinoaniline derivatives, activated blood coagulation factor x inhibitors, and intermediates for producing both |
| 07/19/2000 | EP1020179A2 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 07/19/2000 | EP1019530A1 A method of treating cancer |
| 07/19/2000 | EP1019529A1 A method of treating cancer |
| 07/19/2000 | EP1019400A1 Benzo(5,6)cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors |
| 07/19/2000 | EP1019398A1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives useful for inhibition of farnesyl protein transferase |
| 07/19/2000 | EP1019395A1 Farnesyl transferase inhibiting 2-quinolone derivatives |
| 07/19/2000 | EP1019394A1 PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS |
| 07/19/2000 | EP1019393A1 Novel synthesis |
| 07/19/2000 | EP1019392A1 Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases |